WJ Interests’s Tvardi Therapeutics TVRD Stock Holding History

WJ Interests’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-56	Closed	-$21.5K	–	71
2022 Q4	$21.5K	Buy	+56	New	+$21.3K	0.02%	49

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WJ Interests's TVRD Position: Q1 2023 in Review

WJ Interests sold out of Tvardi Therapeutics (TVRD) in Q1 2023, closing a stake of 56 shares — an estimated $21.5K sold.

WJ Interests first reported a position in TVRD in Q4 2022 and held it in 1 quarter. The position peaked at $21.5K in Q4 2022. 162 funds tracked by Wall St. Rank hold TVRD as of Q1 2023.

WJ Interests reported no remaining Tvardi Therapeutics position as of Q1 2023 after selling out during the quarter.
WJ Interests sold 56 Tvardi Therapeutics shares in Q1 2023, an estimated $21.5K.
WJ Interests first reported a position in Tvardi Therapeutics in Q4 2022 and held it in 1 quarter.
WJ Interests's Tvardi Therapeutics position peaked at $21.5K in Q4 2022.
162 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2023.

Based on WJ Interests's 13F filing for Q1 2023, filed 13 Apr 2023.